S&P 500 Energy Sector SEC Filings — April 15, 2026

15-04-2026

Bioxytran, Inc. reported a reduced net loss of $2,123,077 for the year ended December 31, 2025, compared to $2,366,681 in 2024, driven by decreases in sales and marketing expenses ($64,500 vs. $336,125) and stock-based compensation ($197,377 vs. $634,025), as well as officer salary forfeitures. However, legal and accounting costs increased to $204,870 from $92,149 due to auditor change, miscellaneous G&A rose slightly to $179,594, and the company conducted multiple private placements issuing over 20 million shares for approximately $1 million total, including dilutive issuances at low prices like $0.025/share. Other income/expenses improved to $280,568 from $156,937, aided by derivative fair value gains and debt forgiveness.

• ·Officers forfeited 50% of salaries in 2025 contributing to payroll decrease.
• ·Stock-based compensation in 2025 included $156,655 to affiliates vs. $349,929 in 2024.
• ·Private placements claimed exemptions under Section 4(a)(2)/Rule 506 Reg D, Rule 3(a)(9), or Rule 701.
• ·Debt forgiveness of $133,867 in 2025; no non-controlling interest loss in 2025 vs. $13,324 in 2024.
• ·Loss per share remained flat at $(0.02) basic and diluted both years.

15-04-2026

John Marshall Bancorp, Inc. announced on April 15, 2026, the initiation of equity research coverage on its common stock by Raymond James & Associates, Inc. The press release detailing this event is attached as Exhibit 99.1. This development is filed under Items 8.01 and 9.01 of Form 8-K.

15-04-2026

Hall Chadwick Acquisition Corp's 10-K filing details compensation to sponsor Hall Chadwick Capital LLC, including 7,883,293 Class B Ordinary Shares for $25,000 and 407,000 Private Placement Units for $4,070,000, along with ongoing $20,000 monthly administrative support and potential loans up to $300,000 and $2,500,000. Founder shares held by the sponsor and individuals including Alex Bono, Peter Beckhouse, Aaron Dominish, Gregory Woszczalski, Chris Dirckze, and Matthew Hudson are subject to lock-up restrictions until 180 days post-initial business combination or earlier if Class A shares exceed $12.00 for 20 trading days within a 30-day period starting 150 days after. The filing includes audited financial statements and standard risk disclosures on post-acquisition debt impacts, with no operational performance metrics as the company remains pre-business combination.

• ·Anti-dilution protection for sponsor and Class B holders upon conversion to Class A shares at greater than one-to-one ratio.
• ·Potential consulting, success, or finder fees to sponsor, officers, directors, advisors, or affiliates from funds outside trust account.
• ·Transfer restrictions on founder shares include exceptions for affiliates, family gifts, estate distributions, and pro rata sponsor distributions.
• ·Risks include substantial cash flow used for debt principal/interest post-acquisition, limiting dividends, expenses, and acquisitions; borrowing limitations versus less-levered competitors; potential change in control from share issuances affecting NOL carryforwards and management.

15-04-2026

On April 9 and 14, 2026, Zapata Quantum, Inc. sold 3,750 shares of Series D Convertible Preferred Stock and Warrants to purchase 4,270,098 shares of common stock to accredited investors for gross proceeds of $3,750,000, as part of an ongoing offering of up to 15,000 Series D shares (convertible into 34,160,784 common shares) and warrants for up to 17,080,392 common shares, targeting total gross proceeds of up to $15,000,000. Proceeds will be used for working capital and general corporate purposes. Craig-Hallum Capital Group, LLC and Odeon Capital Group LLC acted as placement agents, receiving warrants equal to 2% of convertible shares and a 6% cash fee.

• ·Sales exempt from registration under Section 4(a)(2) of Securities Act and Rule 506(b).
• ·Terms previously disclosed in 8-K filed April 8, 2026.
• ·Company is an emerging growth company.

15-04-2026

On April 9, 2026, Hallador Energy Company's Board approved the 2026 Executive Officer Plan, replacing the expired 2024 plan, with base salary increases for named executives: Brent Bilsland (CEO) to $800,000 (+18.5% from $675,000), Todd Telesz (CFO) to $525,000 (+5% from $500,000), and Heath Lovell (COO) to $500,000 (+11.1% from $450,000). The plan includes target performance bonuses of $500,000, $200,000, and $300,000 respectively, tied to safety, Adjusted EBITDA ($68.0M target), discretionary, and strategic goals, plus one-time RSU grants valued at approximately $1,200,000, $275,000, and $400,000. New severance and change-in-control retention provisions were also established, including lump sum payments up to $2,400,000 for Bilsland.

• ·RSUs vest ratably on March 31, 2027, 2028, and 2029; accelerate fully on change in control.
• ·Performance bonuses paid in March 2027 post-audit, subject to continued service through Dec 31, 2026.
• ·Safety goals based on 2022-2025 national averages for Sunrise Coal and Hallador Power.
• ·Severance equals 12 months base salary (effective April 1, 2026) plus prior year bonus.
• ·Change-in-control retention requires 3-month post-closing work agreement with acquirer.

15-04-2026

A Paradise Acquisition Corp. announced via Rule 425 filing that the SEC declared effective the registration statement for its business combination with Enhanced Ltd, expected to close and trade as Enhanced Group Inc. ($ENHA) on NYSE in early May 2026, subject to customary conditions. The post by Christian Angermayer highlights the Enhanced Games with a $25M prize pool launching May 24 in Las Vegas, alongside the Live Enhanced telehealth platform and athlete data research, achieving 61% brand awareness and 67% positive sentiment in a survey. While promotional, it notes risks including Enhanced's unproven business model, limited operating history, and minimal revenue to date.

• ·SEC registration statement declared effective on April 15, 2026
• ·Expected trading start: early May 2026 under ticker $ENHA on NYSE
• ·First Enhanced Games scheduled for May 24, 2026 in Las Vegas
• ·Athletes training in Abu Dhabi under clinical trial oversight by Abu Dhabi Department of Health